Medicare had banned coverage of weight-loss drugs for 23 years, and what happens next isn't as simple as the headlines ...
March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap ...
Medicare Advantage insurers leaving certain markets affected more than 1 in 10 Americans enrolled in such plans with prescription drug coverage, a KFF analysis shows.
The proposal, expected to begin as early as April 2026, would provide Medicare beneficiaries with up to $500 annually to purchase CBD products. Supporters argue the program could expand access to ...
To date, every court that has considered substantive challenges to the Medicare drug price negotiation program has ruled against the pharmaceutical industry, dismissing both constitutional and ...
A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare ...
But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...
Drug-related provisions of a landmark Biden-era law were tied to a decline in cost-related medication nonadherence among ...
The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...
Eli Lilly warns some Medicare plans may exceed the $50 monthly cap for weight‑loss drugs under a new CMS model.
3dOpinion
Medicare Advantage is facing a reality check — and seniors are the ones who will pay for it
Medicare is the most remarkable advancement in medical-care reimbursement in American history.
A lesser‑known Medicare deadline can trigger higher monthly premiums if you miss it. We explain which date to watch and how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results